The p110β isoform of phosphoinositide 3-kinase signals downstream of G protein-coupled receptors and is functionally redundant with p110γ

  1. Julie Guillermet-Guibert*,
  2. Katja Bjorklof*,
  3. Ashreena Salpekar*,
  4. Cristiano Gonella*,
  5. Faruk Ramadani,
  6. Antonio Bilancio*,
  7. Stephen Meek,
  8. Andrew J. H. Smith,
  9. Klaus Okkenhaug, and
  10. Bart Vanhaesebroeck*,§
  1. *Center for Cell Signaling, Institute of Cancer, Queen Mary University of London, Charterhouse Square, London EC1M 6BQ, United Kingdom;
  2. Laboratory of Lymphocyte Signaling and Development, Babraham Institute, Cambridge CB2 3AT, United Kingdom; and
  3. Gene Targeting Laboratory, The Institute for Stem Cell Research, University of Edinburgh, West Mains Road, Edinburgh EH9 3JQ, United Kingdom
  1. Edited by Peter K. Vogt, The Scripps Research Institute, La Jolla, CA, and approved April 7, 2008 (received for review August 16, 2007)

Abstract

The p110 isoforms of phosphoinositide 3-kinase (PI3K) are acutely regulated by extracellular stimuli. The class IA PI3K catalytic subunits (p110α, p110β, and p110δ) occur in complex with a Src homology 2 (SH2) domain-containing p85 regulatory subunit, which has been shown to link p110α and p110δ to Tyr kinase signaling pathways. The p84/p101 regulatory subunits of the p110γ class IB PI3K lack SH2 domains and instead couple p110γ to G protein-coupled receptors (GPCRs). Here, we show, using small-molecule inhibitors with selectivity for p110β and cells derived from a p110β-deficient mouse line, that p110β is not a major effector of Tyr kinase signaling but couples to GPCRs. In macrophages, both p110β and p110γ contributed to Akt activation induced by the GPCR agonist complement 5a, but not by the Tyr kinase ligand colony-stimulating factor-1. In fibroblasts, which express p110β but not p110γ, p110β mediated Akt activation by the GPCR ligands stromal cell-derived factor, sphingosine-1-phosphate, and lysophosphatidic acid but not by the Tyr kinase ligands PDGF, insulin, and insulin-like growth factor 1. Introduction of p110γ in these cells reduced the contribution of p110β to GPCR signaling. Taken together, these data show that p110β and p110γ can couple redundantly to the same GPCR agonists. p110β, which shows a much broader tissue distribution than the leukocyte-restricted p110γ, could thus provide a conduit for GPCR-linked PI3K signaling in the many cell types where p110γ expression is low or absent.

Footnotes

  • §To whom correspondence should be addressed. E-mail: bart.vanh{at}qmul.ac.uk
  • Author contributions: J.G.-G., K.B., A.S., C.G., F.R., A.B., S.M., A.J.H.S., K.O., and B.V. designed research; J.G.-G., K.B., A.S., C.G., F.R., A.B., and S.M. performed research; J.G.-G., K.B., A.S., C.G., F.R., A.B., S.M., A.J.H.S., K.O., and B.V. analyzed data; and J.G.-G. and B.V. wrote the paper.

  • Conflict of interest: B.V. is a consultant for PIramed (Slough, UK) and AstraZeneca.

  • This article is a PNAS Direct Submission.

  • This article contains supporting information online at www.pnas.org/cgi/content/full/0707761105/DCSupplemental.

« Previous | Next Article »Table of Contents